Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver

Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver

Background: Fatty liver, a major health problem worldwide, is the earliest pathological change in the progression of alcohol-associated (AFL) and non-alcoholic fatty liver disease (NAFL). Though the causes of AFL and NAFL differ, both share similar histological and some common pathophysiological cha...

Full description

Bibliographic Details
Main Authors:	Karuna Rasineni, Clayton W. Jordan, Paul G. Thomes, Jacy L. Kubik, Elizabeth M. Staab, Sarah A. Sweeney, Geoffrey A. Talmon, Terrence M. Donohue, Mark A. McNiven, Kusum K. Kharbanda, Carol A. Casey
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Physiology
Subjects:	alcohol-associated fatty liver disease non-alcoholic fatty liver disease starvation hepatic lipid metabolism adipose lipolysis liver-adipose crosstalk
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2021.625352/full

Similar Items

Lipophagy and Alcohol-Induced Fatty Liver
by: Li Yang, et al.
Published: (2019-05-01)

Acute ethanol-induced liver injury is prevented by betaine administration
by: Madan Kumar Arumugam, et al.
Published: (2022-10-01)

Lipidomic Analysis of Liver Lipid Droplets after Chronic Alcohol Consumption with and without Betaine Supplementation
by: Madan Kumar Arumugam, et al.
Published: (2023-03-01)

Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
by: Madan Kumar Arumugam, et al.
Published: (2023-10-01)

Editorial: Alcohol-associated liver disease—From pathogenesis to treatment
by: Kusum K. Kharbanda, et al.
Published: (2022-10-01)

Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)

Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to LPS/Galactosamine Liver Injury and Protection by Betaine Administration
by: Karuna Rasineni, et al.
Published: (2020-12-01)

Beneficial Effects of Betaine: A Comprehensive Review
by: Madan Kumar Arumugam, et al.
Published: (2021-05-01)

Role of Elevated Intracellular S-Adenosylhomocysteine in the Pathogenesis of Alcohol-Related Liver Disease
by: Madan Kumar Arumugam, et al.
Published: (2020-06-01)

Meta-Analysis of Non-Alcoholic Fatty Liver Disease and Electromechanical Reconstruction of Myocardium
by: V. A Tretyakova, et al.
Published: (2022-02-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Multiomics Approach Captures Hepatic Metabolic Network Altered by Chronic Ethanol Administration
by: Isin Tuna Sakallioglu, et al.
Published: (2022-12-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin
by: Kusum K. Kharbanda, et al.
Published: (2023-02-01)

The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
by: George Chen, et al.
Published: (2023-02-01)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
by: Hyunwoo Oh, et al.
Published: (2023-02-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Association of Lipid Profile and Liver Parameters with Different Grades of Non-alcoholic Fatty Liver Disease
by: Drutpal Baghel, et al.
Published: (2023-03-01)

A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
by: Jiang YJ, et al.
Published: (2024-04-01)

Correction of liver changes caused by alcohol rates with probiotics
by: Zhadyra Orynbayeva, et al.
Published: (2024-10-01)

Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise
by: Thomai Mouskeftara, et al.
Published: (2024-03-01)

TG: HDL, AST: ALT, A:G Ratios in Alcoholic and Non-alcoholic Fatty Liver patients
by: Abhinav Manish, et al.
Published: (2024-07-01)

New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
by: Xu Zhang, et al.
Published: (2017-06-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study
by: Hui Liu, et al.
Published: (2025-01-01)

Nutritional Management in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Sepideh Mahboobi, et al.
Published: (2015-07-01)

Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
by: Divyavani Gowda, et al.
Published: (2023-11-01)

Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)

Association between non-alcoholic fatty liver disease and epicardial adipose tissue volume with cardiometabolic risk in coronary heart disease
by: Hany Samir Rasmy, et al.
Published: (2022-06-01)

Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01)

Protective Effects of Korean Red Ginseng against Alcohol-Induced Fatty Liver in Rats
by: Hyo Jin Lee, et al.
Published: (2015-06-01)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
by: Teodora Biciusca, et al.
Published: (2023-10-01)

Recent Advances in Understanding the Complexity of Alcohol-Induced Pancreatic Dysfunction and Pancreatitis Development
by: Karuna Rasineni, et al.
Published: (2020-04-01)

Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis
by: Wei Wang, et al.
Published: (2023-09-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
by: Hwi Seung Kim, et al.
Published: (2023-01-01)

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
by: Hyunwoo Oh, et al.
Published: (2016-09-01)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
by: Ju Hyun Shim
Published: (2020-04-01)